Brief: ImmuCell Q1 Sales Up 46% To $6.0 Mln
11/04/2022 21:30
April 11 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES RECORD PRELIMINARY, UNAUDITED SALES
RESULTS
FOR FIRST QUARTER OF 2022
* Q1 SALES ROSE 46 PERCENT TO $6.0 MILLION
Source text for Eikon: ID:nGNX9glfLc
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year